Reduced blood agmatine level in early-onset schizophrenia

Schizophr Res. 2020 Aug:222:528-529. doi: 10.1016/j.schres.2020.05.006. Epub 2020 May 20.

Authors

Burak M Baytunca¹, Tuğba Kalyoncu², Burcu Özbaran², Sezen Köse², Dost Öngür³, Tayfun Uzbay⁴

Affiliations

¹ University of Utah, Department of Psychiatry, Salt Lake City, UT, USA. Electronic address: baytunca@yahoo.com.
² Ege University, School of Medicine, Department of Child and Adolescent Psychiatry, İzmir, Turkey.
³ Division of Psychotic Disorders, McLean Hospital, Harvard Medical School, Belmont, MA, USA. Electronic address: dongur@partners.org.
⁴ Neuropsychopharmacology Application and Research Center (NPARC), Üsküdar University, İstanbul, Turkey.

PMID: 32446703
DOI: 10.1016/j.schres.2020.05.006

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Agmatine*
Humans
Schizophrenia*

Substances

Agmatine